Literature DB >> 11576937

Central nervous dysfunction in uremia.

M J Smogorzewski1.   

Abstract

The mechanisms of central nervous system dysfunction in uremia are multifactorial and only partially characterized. Studies using sealed presynaptic nerve terminals (synaptosomes) for in vitro ion transport and metabolism of neurotransmitter in chronic renal failure (CRF) neuronal cell culture and in vivo brain structure microdialysis generated significant new information. An increase in total calcium content of the cerebral cortex accompanied by increased levels of cytosolic calcium ([Ca(2+)]i) in synaptosomes are common findings in rats with CRF. Mechanisms leading to the increase in [Ca(2+)]i include increased calcium uptake mediated by parathyroid hormone and decreased activity of Na(+),K(+)-adenosine triphosphatase (ATPase) and Ca(2+)-ATPase of synaptosomes in CRF rats. Moreover, these synaptosomes respond inappropriately to depolarization, which can impair neurotransmitter metabolism. Brain gamma-aminobutyric acid content, norepinephrine, and acetylcholine release uptake and degradation are affected by uremia. These may lead to certain somatic, behavioral, and motor dysfunctions in uremia. Many derangements of the central nervous system in uremia appear to be mediated by secondary hyperparathyroidism of CRF because parathyroidectomy of animals with CRF prevented the increase in basal levels of [Ca(2+)]i and derangements in neurotransmitter metabolism. The role of other neurotoxins, such as guanidinosuccinic acid, are also reviewed.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11576937     DOI: 10.1053/ajkd.2001.27419

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  11 in total

1.  Neuropsychological function in relation to serum parathyroid hormone and serum 25-hydroxyvitamin D levels. The Tromsø study.

Authors:  Rolf Jorde; Knut Waterloo; Farahnaz Saleh; Egil Haug; Johan Svartberg
Journal:  J Neurol       Date:  2005-11-14       Impact factor: 4.849

2.  Association between abnormal thalamic metabolites and sleep disturbance in patients with end-stage renal disease.

Authors:  Xueying Ma; Yan Zhang; Shaohui Ma; Peng Li; Dun Ding; Hua Liu; Jixin Liu; Ming Zhang
Journal:  Metab Brain Dis       Date:  2018-07-04       Impact factor: 3.584

3.  Reduced white matter integrity and cognitive deficits in maintenance hemodialysis ESRD patients: a diffusion-tensor study.

Authors:  Ruijie Zhang; Kai Liu; Linfeng Yang; Tao Zhou; Shaowen Qian; Bo Li; Zhaohui Peng; Min Li; Shengpeng Sang; Qingjun Jiang; Gang Sun
Journal:  Eur Radiol       Date:  2014-10-18       Impact factor: 5.315

Review 4.  Kidney-brain crosstalk in the acute and chronic setting.

Authors:  Renhua Lu; Matthew C Kiernan; Anne Murray; Mitchell H Rosner; Claudio Ronco
Journal:  Nat Rev Nephrol       Date:  2015-08-18       Impact factor: 28.314

5.  Effects of endothelin-1 on hepatic stellate cell proliferation, collagen synthesis and secretion, intracellular free calcium concentration.

Authors:  Chuan-Yong Guo; Jian-Ye Wu; Yun-Bin Wu; Min-Zhang Zhong; Han-Ming Lu
Journal:  World J Gastroenterol       Date:  2004-09-15       Impact factor: 5.742

6.  Brain Na+/K+-ATPase α-subunit isoforms and aestivation in the African lungfish, Protopterus annectens.

Authors:  Kum C Hiong; Yuen K Ip; Wai P Wong; Shit F Chew
Journal:  J Comp Physiol B       Date:  2014-04-03       Impact factor: 2.200

7.  Kidney disease as a determinant of cognitive decline and dementia.

Authors:  Thorleif Etgen
Journal:  Alzheimers Res Ther       Date:  2015-03-17       Impact factor: 6.982

8.  Neurological, psychological, and cognitive disorders in patients with chronic kidney disease on conservative and replacement therapy.

Authors:  Silvia Lai; Oriano Mecarelli; Patrizia Pulitano; Roberto Romanello; Leonardo Davi; Alessia Zarabla; Amalia Mariotti; Maria Carta; Giorgia Tasso; Luca Poli; Anna Paola Mitterhofer; Massimo Testorio; Nicla Frassetti; Paola Aceto; Alessandro Galani; Carlo Lai
Journal:  Medicine (Baltimore)       Date:  2016-11       Impact factor: 1.889

9.  Renal Denervation Improves the Baroreflex and GABA System in Chronic Kidney Disease-induced Hypertension.

Authors:  Hsin-Hung Chen; Pei-Wen Cheng; Wen-Yu Ho; Pei-Jung Lu; Chi-Cheng Lai; Yang-Ming Tseng; Hua-Chang Fang; Gwo-Ching Sun; Michael Hsiao; Chun-Peng Liu; Ching-Jiunn Tseng
Journal:  Sci Rep       Date:  2016-12-05       Impact factor: 4.379

10.  Brain Microstructural Abnormalities Are Related to Physiological Alterations in End-Stage Renal Disease.

Authors:  Zhigang Bai; Xiaofen Ma; Junzhang Tian; Jianwei Dong; Jinlong He; Wenfeng Zhan; Lijuan Xu; Yikai Xu; Guihua Jiang
Journal:  PLoS One       Date:  2016-05-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.